O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+6.32%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$9.11B
AUM Growth
+$9.11B
(+10%)
Cap. Flow
+$635M
Cap. Flow
% of AUM
6.97%
Top 10 Holdings %
Top 10 Hldgs %
38.17%
Holding
140
New
19
Increased
34
Reduced
21
Closed
18
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$218M |
| 2 |
Cooper Companies
COO
|
$178M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$92.3M |
| 4 |
SHPG
Shire pic
SHPG
|
$81.3M |
| 5 |
WMGI
Wright Medical Group Inc
WMGI
|
$74.1M |
Top Sells
| 1 |
ITMN
INTERMUNE INC
ITMN
|
$240M |
| 2 |
Viatris
VTRS
|
$172M |
| 3 |
AGN
ALLERGAN INC
AGN
|
$115M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$89.3M |
| 5 |
Pfizer
PFE
|
$41.8M |
Sector Composition
| 1 | Healthcare | 88.25% |
| 2 | Financials | 0.07% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESRX
26
DELISTED
Express Scripts Holding Company
ESRX
| $148M | 1.55% | 2,098,000 +19,000 | +0.9% | +$1.34M |
|
|
HNT
27
DELISTED
HEALTH NET INC
HNT
| $142M | 1.48% | 3,070,400 +195,000 | +7% | +$8.99M |
|
28
McKesson
MCK
$85.4B
| $138M | 1.44% | 708,000 +48,000 | +7% | +$9.34M |
|
29
Regeneron Pharmaceuticals
REGN
$61.5B
| $133M | 1.39% | 369,600 +43,000 | +13% | +$15.5M |
|
30
Zimmer Biomet
ZBH
$21B
| $127M | 1.32% | 1,259,700 +81,000 | +7% | +$8.14M |
|
31
Molina Healthcare
MOH
$9.8B
| $116M | 1.21% | 2,737,900 +175,000 | +7% | +$7.4M |
|
|
TRNX
32
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $115M | 1.2% | 4,805,000 +731,200 | +18% | +$17.5M |
|
33
Neurocrine Biosciences
NBIX
$13.8B
| $90.8M | 0.95% | 5,793,600 +1,117,900 | +24% | +$17.5M |
|
34
Stryker
SYK
$150B
| $81M | 0.85% | 1,002,600 +8,000 | +0.8% | +$646K |
|
|
35
Pfizer
PFE
$141B
| $79M | 0.82% | 2,670,000 -1,412,000 | -35% | -$41.8M |
|
36
Arrowhead Research
ARWR
$3.05B
| $76.5M | 0.8% | 5,178,200 +220,400 | +4% | +$3.26M |
|
|
WMGI
37
DELISTED
Wright Medical Group Inc
WMGI
| $74.1M | 0.77% | +2,444,000 | New | +$74.1M |
|
38
Insulet
PODD
$23.9B
| $72M | 0.75% | 1,953,000 | – | – |
|
|
NPSP
39
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $68M | 0.71% | 2,616,000 +2,065,800 | +375% | +$53.7M |
|
|
INFI
40
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $63.6M | 0.66% | 4,736,900 | – | – |
|
|
STJ
41
DELISTED
St Jude Medical
STJ
| $61.5M | 0.64% | 1,023,600 -640,000 | -38% | -$38.5M |
|
|
OTIC
42
DELISTED
Otonomy, Inc.
OTIC
| $54.2M | 0.57% | +2,256,398 | New | +$54.2M |
|
|
AFFX
43
DELISTED
AFFYMETRIX INC
AFFX
| $52.4M | 0.55% | 6,568,000 | – | – |
|
|
ALXN
44
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $51.7M | 0.54% | 312,000 | – | – |
|
45
Standard BioTools
LAB
$481M
| $51.5M | 0.54% | 2,100,200 +238,000 | +13% | +$5.83M |
|
46
Puma Biotechnology
PBYI
$254M
| $50.8M | 0.53% | 212,900 -5,200 | -2% | -$1.24M |
|
47
Johnson & Johnson
JNJ
$427B
| $45.1M | 0.47% | 423,000 -59,000 | -12% | -$6.29M |
|
48
OraSure Technologies
OSUR
$242M
| $38.8M | 0.41% | 5,372,000 | – | – |
|
|
QGENF
49
DELISTED
QIAGEN NV
QGENF
| $38.7M | 0.4% | 1,700,000 +918,600 | +118% | +$20.9M |
|
|
AFMD
50
DELISTED
Affimed
AFMD
| $36.6M | 0.38% | +5,814,630 | New | +$36.6M |
|